Start Submission Become a Reviewer

Reading: Peripartum Cardiomyopathy: A Contemporary Review

Download

A- A+
Alt. Display

Review Articles

Peripartum Cardiomyopathy: A Contemporary Review

Authors:

Tina Shah ,

Baylor College of Medicine, Houston, Texas, US
About Tina
M.D.
X close

Sameer Ather,

Baylor College of Medicine, Houston, Texas, US
About Sameer
M.D., Ph.D.
X close

Chirag Bavishi,

University of Texas, Houston, Texas, US
About Chirag
M.D., M.P.H.
X close

Arvind Bambhroliya,

Baylor College of Medicine, Houston, Texas, US
About Arvind
M.D., M.P.H.
X close

Tony Ma,

Baylor College of Medicine, Houston, Texas; Michael E. DeBakey VA Medical Center, Houston, Texas, US
About Tony
M.D.
X close

Biykem Bozkurt

Baylor College of Medicine, Houston, Texas; Michael E. DeBakey VA Medical Center, Houston, Texas, US
About Biykem
M.D., Ph.D.
X close

Abstract

Peripartum cardiomyopathy is a rare and potentially fatal disease. Though approximately half of the patients recover, the clinical course is highly variable and some patients develop refractory heart failure and persistent left ventricular systolic dysfunction. It is diagnosed when women present with heart failure secondary to left ventricular systolic dysfunction towards the end of pregnancy or in the months following delivery, where no other cause of heart failure is found. Etiology remains unclear, and treatment is similar to other cardiomyopathies and includes evidence-based standard heart failure management strategies. Experimental strategies such as intravenous immunoglobulin and bromocriptine await further clinical validation.

How to Cite: 1. Shah T, Ather S, Bavishi C, Bambhroliya A, Ma T, Bozkurt B. Peripartum Cardiomyopathy: A Contemporary Review. Methodist DeBakey Cardiovascular Journal. 2013;9(1):38-43. DOI: http://doi.org/10.14797/mdcj-9-1-38
Published on 01 Jan 2013.
Peer Reviewed

Downloads

  • PDF (EN)